Viral infections in patients with chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 2, 2008, Pages 89-94

  Varkey, Jay B ^a   Varkey, Basil ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chronic obstructive pulmonary disease exacerbations; PCR technology; Respiratory viral infections

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT; CORTICOSTEROID; PLECONARIL; RUPINTRIVIR;

ADENOVIRUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMON COLD; CORONAVIRUS; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; HUMAN; INFLUENZA; METAPNEUMOVIRUS; MICROBIAL COLONIZATION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; RNA VIRUS INFECTION; VIRUS INFECTION;

DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; HUMANS; MORBIDITY; POLYMERASE CHAIN REACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES; VIRUSES;

EID: 40049083543     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3282f4a99f     Document Type: Review

References (54)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
2. Lopez AD, Murray CC. The global burden of disease. Nat Med 1998; 4:1241-1243.
3. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117:5S-9S.
4. Mallia P, Johnston SL. How viral infections cause exacerbations of airway diseases. Chest 2006; 130:1203-1210. This is an excellent comprehensive review of the evidence for viruses as a cause of exacerbations of COPD and asthma. It focuses on inflammatory mediators and cellular mechanisms of virus-induced exacerbations.
5. Proud D, Chow CW. Role of viral infections in asthma and chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2006; 35:513-518. This paper is an excellent translational review of the evidence that implicates viral infections in the pathogenesis of asthma and COPD and as a major trigger of exacerbations. It focuses on pathogenesis and implications on future treatment options.
6. Seemungal T, Harper-Own R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1618-1623.
7. Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case-control study. Thorax 2003; 58:37-42.
8. Tan WC, Xiang X, Qiu D, et al. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003; 115:272-277.
9. Cameron RJ, de Wit D, Welsh TN, et al. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 2006; 32:1022-1029. This study characterizes and quantifies the incidence of common infectious agents in a prospective cohort of 105 ICU patients requiring mechanical ventilation for exacerbations of COPD. This is the first study to use PCR to detect viruses in ventilated COPD patients.
10. Smith CB, Kanner RE,Golden CA, et al. Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis 1980; 141:271-280.
11. Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA. Effect of environmental temperature on symptoms, lung function and mortality in COPD patients. Eur Respir J 1999; 13:844-849.
12. Gorse G, O'Connor TZ, Young SL, et al. Impact of winter respiratory virus season on patients with COPD and association with influenza vaccination. Chest 2006; 130:1109-1116. This multicenter study demonstrates that respiratory viral infections adversely affect lung function, performance status, and health-related quality of life in an older veteran population.
13. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1:115-120.
14. Greenberg SB, Allen M, Wilson J, et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:167-173.
15. Beckham JD, Cadena A, Lin J, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 2005; 50:322-330.
16. Rohde G, Borg I, Arinir U, et al. Relevance of human metapneumovirus in exacerbations of COPD. Respir Res 2005; 6:150.
17. Martinello RA, Esper F, Weibel C, et al. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 2006; 53:248-254. This observational cohort study conducted during the winter respiratory viral season demonstrated significantly higher rates of human metapneumovirus-associated COPD exacerbations compared with Rohde et al. [16].
18. Ko FWS, Ip M, Chan PKS, et al. Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 2007; 132:900-908. This prospective cohort study provides an excellent description of the epidemiology of viral infections among patients in Hong Kong who were hospitalized for COPD exacerbations. This is the first large-scale prospective study conducted in Asia on the viral etiology of patients hospitalized with COPD exacerbations that uses PCR on nasopharyngeal aspiration specimens.
19. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173:1114-1121. This is the first study in which both viral and bacterial infection and inflammation were simultaneously assessed at hospital admission and convalescence in sputum obtained from a prospective cohort of patients with severe exacerbations of COPD. This study also suggests that sputum eosinophilia may be a good clinical predictor of viral exacerbations.
20. Wilkinson TM, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006; 129:317-324. This interesting prospective cohort study is the first study to demonstrate that simultaneous identification of bacterial and viral pathogens in sputum at the time of exacerbation is associated with enhanced airway inflammation, increased bacterial load and symptoms, and a larger decrement in lung function.
21. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29:1224-1238. This is an excellent up-to-date review of the etiology, cellular and molecular mechanisms, management and new definition of exacerbations of COPD.
22. Fraenkel DJ, Bardin PG, Sanderson G, et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 129:879-886.
23. Trigg CJ, Nicholson KG, Wang JH, Ireland DC, et al. Bronchial inflammation and the common cold: a comparison of atopic and nonatopic individuals. Clin Exp Allergy 1996; 26:665-676.
24. Papi A, Message SD, Papadopoulos NG, et al. Respiratory viruses and asthma. In: Chung KF, Fabbri LM, editors. European respiratory monograph: asthma. Sheffield, UK: European Respiratory Society; 2003. pp. 223-228.
25. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:871-876. This is the first longitudinal prospective study to investigate the role that RSV may play in the etiology and progression of stable COPD. Researchers demonstrate that RSV RNA can be detected in patients with stable COPD and that detection is associated with higher levels of airway inflammation, greater airway bacterial loads, and an accelerated decline in lung function.
26. ••]) that describe a high percentage of patients with stable COPD and chronic detectable RSV.
27. Rätty R, Kleemola M, Melén K, et al. Efficacy of PCR and other diagnostic methods for the detection of respiratory adenoviral infections. J Med Virol 1999; 59:66-72.
28. Magnard C, Valette M, Aymard M, et al. Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses. J Med Virol 1999; 59:215-220.
29. Ko FWS, Ip M, Chan PKS, et al. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007; 131:44-52. This prospective cohort is the first study conducted in Asia to use viral culture and paired serology to characterize the bacteriology and virology in patients hospitalized for COPD exacerbations.
30. Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155:1159-1161.
31. Fleming HE, Little FF, Schnurr D, et al. Rhinovirus-16 colds in health and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 1999; 160:100-108.
32. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181:1875-1884.
33. Ramilo O, Allman W, Chung W, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007; 109: 2066-2077. This interesting study successfully demonstrates that blood leukocyte gene expression patterns can reliably distinguish patients with acute infections caused by influenza A, Escherichia coli, Staphylococcus aureus and Streptococcus pneumoniae, highlighting the potential value of this technology as a future diagnostic tool.
34. Seemungal TA, Harper-Owen R, Bhowmik A, et al. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000; 16:677-683.
35. Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NFkappaB-mediated transcription. J Biol Chem 1999; 274:9707-9720.
36. Arruda E, Boyle TR, Winther B, et al. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis 1995; 171:1329-1333.
37. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:349-355.
38. Sethi S, Muscarella K, Evans N, et al. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118:1557-1565.
39. Qiu Y, Zhu J, Bandi V, et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168:968-975.
40. Gompertz S, O'Brien C, Bayley DL, et al. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17:1112-1119.
41. Gern JE, French DA, Grindle KA, et al. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelia cells. Am J Respir Cell Mol Biol 2003; 28:731-737.
42. Roland M, Bhowmik A, Sapsford RJ, et al. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 2001; 56:30-35.
43. Hadida F, Vieillard V, Mollet L, et al. Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic cells. J Immunol 1999; 163:1105-1109.
44. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55:114-120.
45. Carpagnano GE, Resta O, Foschino-Barbaro MP, et al. Exhaled IL-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur J Pharmacol 2004; 505:169-175.
46. Murphy KR, Eivindson A, Pauksens K, et al. Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled, multicentre study. Clin Drug Invest 2000; 20:333-349.
47. Hayden FG, Herrington DT, Coats TL, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 2003; 36:1523-1532.
48. Hayden FG, Turner RB, Gwaltney JM, et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percentage suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 2003; 47:3907-3916.
49. Barnes PJ, Hansel TT. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet 2004; 364:985-996.
50. Proud D. Nitric oxide and the common cold. Curr Opin Allergy Clin Immunol 2005; 5:37-42.
51. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136:296-307.
52. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778-784.
53. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994; 272:1661-1665.
54. Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination, a randomized controlled study. Chest 2004; 125:2011-2020.